Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Moderna
Pharma
Moderna plots launch of its next potential mRNA vaccine approval
Moderna expects initial approvals of its RSV vaccine to start rolling in during the first half of 2024, teeing up a potential U.S. launch this fall.
Fraiser Kansteiner
May 2, 2024 11:08am
Moderna takes a 'Coffee Break' with new social media series
May 1, 2024 9:05am
Pfizer takes top spot in docs' vaccine ranking by 'huge margin'
May 1, 2024 7:00am
Africa CDC slams Moderna after it halts Kenya plant buildout
Apr 17, 2024 10:28am
Judge pauses Moderna's infringement case against rival Pfizer
Apr 15, 2024 4:47pm
Viatris, eyeing a return to growth, taps Moderna alum as CCO
Apr 15, 2024 10:29am